Computerized clinical decision support systems for drug prescribing and management: A decision-maker-researcher partnership systematic review
Autor: | Jean A. Mackay, Nancy L Wilczynski, Marita Tonkin, Tamara Navarro, Anne Holbrook, Lorraine Weise-Kelly, Brian J Hemens, R. Brian Haynes |
---|---|
Jazyk: | angličtina |
Předmět: |
medicine.medical_specialty
Biomedical Research Prescription Drugs Drug-Related Side Effects and Adverse Reactions MEDLINE Health Informatics 030204 cardiovascular system & hematology Global Health Clinical decision support system Health informatics law.invention Health administration User-Computer Interface 03 medical and health sciences 0302 clinical medicine Randomized controlled trial law Humans Medicine 030212 general & internal medicine Cooperative Behavior Practice Patterns Physicians' Disease management (health) Monitoring Physiologic Medicine(all) lcsh:R5-920 Evidence-Based Medicine business.industry Health Policy Health services research Public Health Environmental and Occupational Health Disease Management General Medicine Evidence-based medicine Consumer Behavior Decision Support Systems Clinical United States 3. Good health Family medicine Systematic Review lcsh:Medicine (General) business Algorithms |
Zdroj: | Implementation Science, Vol 6, Iss 1, p 89 (2011) Implementation Science : IS |
ISSN: | 1748-5908 |
DOI: | 10.1186/1748-5908-6-89 |
Popis: | Background Computerized clinical decision support systems (CCDSSs) for drug therapy management are designed to promote safe and effective medication use. Evidence documenting the effectiveness of CCDSSs for improving drug therapy is necessary for informed adoption decisions. The objective of this review was to systematically review randomized controlled trials assessing the effects of CCDSSs for drug therapy management on process of care and patient outcomes. We also sought to identify system and study characteristics that predicted benefit. Methods We conducted a decision-maker-researcher partnership systematic review. We updated our earlier reviews (1998, 2005) by searching MEDLINE, EMBASE, EBM Reviews, Inspec, and other databases, and consulting reference lists through January 2010. Authors of 82% of included studies confirmed or supplemented extracted data. We included only randomized controlled trials that evaluated the effect on process of care or patient outcomes of a CCDSS for drug therapy management compared to care provided without a CCDSS. A study was considered to have a positive effect (i.e., CCDSS showed improvement) if at least 50% of the relevant study outcomes were statistically significantly positive. Results Sixty-five studies met our inclusion criteria, including 41 new studies since our previous review. Methodological quality was generally high and unchanged with time. CCDSSs improved process of care performance in 37 of the 59 studies assessing this type of outcome (64%, 57% of all studies). Twenty-nine trials assessed patient outcomes, of which six trials (21%, 9% of all trials) reported improvements. Conclusions CCDSSs inconsistently improved process of care measures and seldomly improved patient outcomes. Lack of clear patient benefit and lack of data on harms and costs preclude a recommendation to adopt CCDSSs for drug therapy management. |
Databáze: | OpenAIRE |
Externí odkaz: |